The outlook of companies tied to the drug's past presents a challenging investment landscape. While the initial boom generated substantial returns , generic copies have significantly eroded revenue. Investing https://bookmarkbirth.com/story22293111/the-copyright-and-the-pharmaceutical-sector-a-speculative-opportunity